Semax
Compoundable (Rx)Nootropic Peptides · Cognitive Enhancement
Semax is a synthetic peptide derived from ACTH (adrenocorticotropic hormone, fragment 4-10) developed by the Russian Institute of Molecular Genetics.
What is Semax?
Semax is a synthetic peptide derived from ACTH (adrenocorticotropic hormone, fragment 4-10) developed by the Russian Institute of Molecular Genetics. It is approved in Russia and Ukraine for treating stroke, cognitive disorders, and peptic ulcers. It has gained popularity in the biohacking community as a nootropic for focus, memory, and neuroprotection.
Also known as: MEHFPGP, Semax acetate
How Does Semax Work?
Increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression. Modulates dopaminergic and serotonergic neurotransmission. Enhances neuroplasticity and protects against oxidative stress. Unlike ACTH, it does not stimulate adrenal cortisol production.
What is Semax Used For?
- Cognitive enhancement
- Neuroprotection
- Focus & attention
- Stroke recovery
- Anxiety reduction
Potential Side Effects
- Nasal irritation
- Headache (rare)
- Dizziness (uncommon)
Contraindications
- Pregnancy
- Seizure disorders
- Children
FDA Legal Status
United States — FDA
Compoundable (Rx)Category 1 (restored 2026)
Related Peptides
Selank
Compoundable (Rx)Nootropic Peptides
Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, developed at the Russian Insti...
DSIP
Compoundable (Rx)Nootropic Peptides
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide that promotes delta wave (deep) sleep. It was ...
Head-to-head comparisons:
Frequently Asked Questions
How does Semax work as a nootropic?
Is Semax addictive?
Quick Facts
- Legal Status (USA)
- Compoundable (Rx)
- FDA Category
- Category 1 (restored 2026)
- Evidence Rating
- BModerate Evidence (Some Human Data)
- Class / Subclass
- Nootropic Peptides / Cognitive Enhancement
- Administration
- nasal, subcutaneous
- Typical Dosage
- 200-600mcg nasal, 1-2x daily
- Half-Life
- ~3-5 minutes (rapid onset, sustained effects)
- Year Discovered
- 1982
Sources
Last updated: 2026-04-01
Sources & references
Primary sources used for the dosing, mechanism, side-effect, and regulatory claims on this page. Verify time-sensitive information (regulatory status, prescribing details) on the source before relying on it for medical decisions. See our disclaimer.
- PubMed PMID 17369778 — peer-reviewed primary literature on Semax.
- FDA Federal Register — official notice record for FDA regulatory actions and Category 1 / 503A bulk-substance updates.